
浏览全部资源
扫码关注微信
1.河南中医药大学,郑州 450046
2.河南中医药大学 第一附属医院,郑州 450099
倪锦玉,在读博士,从事中医药防治儿童肾脏疾病的研究,E-mail:njy04032340@sina.com
翟文生,博士,主任医师,从事中医药防治儿童肾脏疾病的研究,Tel:0371-66264877,E-mail:zhws65415@sina.com
收稿日期:2021-06-05,
网络出版日期:2021-12-22,
纸质出版日期:2022-02-20
移动端阅览
倪锦玉,翟文生,李乐等.益气化瘀清热方序贯辨证治疗儿童难治性肾病综合征临床疗效观察[J].中国实验方剂学杂志,2022,28(04):116-123.
NI Jin-yu,ZHAI Wen-sheng,LI Le,et al.Sequential Treatment with Syndrome Differentiation on Children's Refractory Nephrotic Syndrome with Yiqi Huayu Qingre Prescription[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(04):116-123.
倪锦玉,翟文生,李乐等.益气化瘀清热方序贯辨证治疗儿童难治性肾病综合征临床疗效观察[J].中国实验方剂学杂志,2022,28(04):116-123. DOI: 10.13422/j.cnki.syfjx.20220494.
NI Jin-yu,ZHAI Wen-sheng,LI Le,et al.Sequential Treatment with Syndrome Differentiation on Children's Refractory Nephrotic Syndrome with Yiqi Huayu Qingre Prescription[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(04):116-123. DOI: 10.13422/j.cnki.syfjx.20220494.
目的
2
评价益气化瘀清热方序贯辨证治疗儿童难治性肾病综合征的临床疗效。
方法
2
将112例难治性肾病综合征患儿随机分为观察组和对照组,观察组57例,对照组55例。对照组给予泼尼松片联合他克莫司治疗,观察组在对照组基础上加用益气化瘀清热方序贯辨证治疗。观察两组治疗后的总有效率;观察两组患儿在治疗前、治疗4,8,16,24,32,40,52周后24小时尿蛋白定量(24 h UTP),血浆白蛋白(ALB),胆固醇(CHO),甘油三酯(TG)及小儿难治性肾病中医生存质量量表积分的变化;观察在治疗期间激素减停并持续到52周的患儿,比较其激素总疗程及总累积量。
结果
2
观察组治疗后总有效率更高(
Z=
-2.052,
P<
0.05);与对照组比较,观察组在每个随访时间节点上24 h UTP均较低,ALB均较高(
P
<
0.05,
P
<
0.01);在治疗4,8,16周时CHO水平与对照组差异无统计学意义,在其余时间节点较对照组低(
P
<
0.05,
P
<
0.01);治疗4,8,16,40周时TG水平与对照组差异无统计学意义,在24,32,52周时较对照组低(
P
<
0.05,
P
<
0.01);观察组的激素总疗程更短(
P
<
0.01),总累积量更少(
P
<
0.01);随着随访时间节点的变化,观察组的中医生存质量量表总分均优于对照组(
P
<
0.05,
P
<
0.01),且治疗后观察组在四个维度(生理功能、独立性因素、社会因素、心理因素)的积分均较对照组高(
P
<
0.05,
P
<
0.01)。
结论
2
益气化瘀清热方序贯辨证治疗儿童难治性肾病综合征临床疗效确切,在缩短激素总疗程、降低激素总累积量方面更有优势,能更好的提高患儿的生存质量。
Objective
2
To evaluate the clinical efficacy of sequential syndrome differentiation of Yiqi Huayu Qingre prescription (YHQ) in the treatment of refractory nephrotic syndrome in children.
Method
2
A total of 112 children with refractory nephrotic syndrome were randomly divided into an observation group (57 cases) and a control group(55 cases). The children in the control group were treated with prednisone tablets combined with tacrolimus,and those in the observation group were treated with YHQ by sequential syndrome differentiation on the basis of the control group. The total effective rates of the two groups after treatment were observed. The 24-hour urinary total protein(24 h UTP),plasma albumin(ALB),cholesterol(CHO),triglycerides(TG), and traditional Chinese medicine quality of life scale scores before treatment and after four weeks,eight weeks,16 weeks,24 weeks,32 weeks,40 weeks,and 52 weeks in the two groups were recorded. The total course of treatment and the total accumulation of hormones were compared among the children with reduced or no hormone treatment till 52 weeks during treatment.
Result
2
The total effective rate in the observation group was higher (
Z=
-2.052,
P<
0.05). The observation group had lower 24 h UTP and higher ALB at each follow-up time point than the control group(
P
<
0.05,
P
<
0.01). At four weeks,eight weeks,and 16 weeks of treatment,there was no statistically significant difference in CHO between the observation group and the control group,and the observation group was lower than the control group in CHO at the rest of the time points (
P
<
0.05,
P
<
0.01). For TG, the observation group was not significantly different from the control group at four weeks,eight weeks,16 weeks,and 40 weeks of treatment,but lower at 24,32,and 52 weeks (
P
<
0.05,
P
<
0.01). The total treatment course of hormones in the observation group was shorter(
P
<
0.01), with less total accumulation(
P
<
0.01). At different follow-up time points,the total score of traditional Chinese medicine quality of life scale in the observation group was superior to that in the control group(
P
<
0.05,
P
<
0.01),and the scores of the observation group in the four dimensions (physiological function,independent factor,social factor,and psychological factor) after treatment were higher than those in the control group(
P
<
0.05,
P
<
0.01).
Conclusion
2
YHQ under sequential syndrome differentiation has a definite clinical effect in treating children with refractory nephrotic syndrome. It has advantages in shortening the total course of hormone treatment and reducing the total accumulation of hormones,and can improve the quality of life of children with refractory nephrotic syndrome.
中华医学会儿科学分会肾脏学组 . 儿童激素敏感、复发/依赖肾病综合征诊治循证指南(2016) [J]. 中华儿科杂志 , 2017 , 55 ( 10 ): 729 - 734 .
全国儿童常见肾脏病诊治现状调研工作组 . 我国儿童激素敏感、复发/依赖肾病综合征诊疗现状的多中心研究 [J]. 中华儿科杂志 , 2014 , 52 ( 3 ): 194 - 200 .
GIBSON K L , HANSRIVIJIT P , FERRIS M E . Emerging agents for the management of nephrotic syndrome:progress to date [J]. Paediatr Drugs , 2016 , 18 ( 1 ): 25 - 29 .
KALLEN R . History of childhood kidney disease and risk of adult end-stage renal disease [J]. N Engl J Med , 2018 , 378 ( 18 ): 1750 .
倪锦玉 , 张寒放 , 杨濛 , 等 . 儿童难治性肾病综合征的中医药治疗研究现状 [J]. 吉林中医药 , 2021 , 41 ( 2 ): 275 - 277 .
刘华 , 翟文生 . 翟文生教授治疗小儿难治性肾病经验介绍 [J]. 新中医 , 2010 , 42 ( 4 ): 97 - 98 .
张秋月 , 翟文生 , 刘翠华 , 等 . 益气化瘀清热方治疗小儿难治性肾病临床观察 [J]. 中国中西医结合儿科学 , 2019 , 11 ( 3 ): 206 - 209 .
翟文生 , 李前前 , 张建 , 等 . 益气化瘀清热方及拆方对脂多糖诱导的大鼠系膜细胞凋亡及其调控基因Bax和Bcl-2蛋白表达的影响 [J]. 时珍国医国药 , 2016 , 27 ( 3 ): 580 - 582 .
翟文生 , 杨濛 , 张建 , 等 . 益气化瘀清热方及其拆方对大鼠肾系膜细胞表达NF- κ B p65 mRNA及其蛋白的影响 [J]. 中华中医药学刊 , 2018 , 36 ( 6 ): 1287 - 1290 .
翟文生 , 杨濛 , 张建 , 等 . 益气化瘀清热方及其拆方对嘌呤霉素氨基核苷损伤小鼠足细胞表达TRPC6的影响 [J]. 中华中医药学刊 , 2018 , 36 ( 1 ): 14 - 18 .
翟文生 , 梁丽 , 张霞 , 等 . 益气化瘀清热方及其拆方对大鼠肾系膜细胞I κ B- α mRNA及蛋白信号通路的影响 [J]. 中华中医药杂志 , 2016 , 31 ( 9 ): 3742 - 3744 .
翟文生 , 杨濛 , 李前前 , 等 . 益气化瘀清热方及其拆方对大鼠肾小球系膜细胞TGF- β RⅠmRNA及其蛋白的影响 [J]. 中华中医药学刊 , 2017 , 35 ( 9 ): 2215 - 2218 .
翟文生 , 杨濛 , 张霞 , 等 . 益气化瘀清热方及其拆方对大鼠肾系膜细胞表达Smad2及泛素mRNA的影响 [J]. 时珍国医国药 , 2017 , 28 ( 5 ): 1047 - 1049 .
翟文生 , 张冰洁 , 张霞 , 等 . 益气化瘀清热方及其拆方对大鼠肾小球系膜细胞表达p38 MAPK mRNA及其蛋白的影响 [J]. 辽宁中医杂志 , 2016 , 43 ( 6 ): 1318 - 1320 .
翟文生 , 袁泉 , 李广 . 益气化瘀清热方及其拆方对体外培养大鼠肾小球系膜细胞产生Ⅲ型胶原蛋白的影响 [J]. 中华中医药杂志 , 2015 , 30 ( 9 ): 3378 - 3380 .
翟文生 , 杨濛 , 李广 , 等 . 益气化瘀清热方及其拆方影响体外培养大鼠MsC增殖、产生Col-Ⅰ的实验研究 [J]. 时珍国医国药 , 2015 , 26 ( 2 ): 499 - 500 .
翟文生 , 杨濛 , 张建 , 等 . 益气化瘀清热方及其拆方对大鼠肾小球系膜细胞TGF- β 1 /Smad3信号通路的影响 [J]. 中华中医药学刊 , 2017 , 35 ( 4 ): 846 - 848 .
李乐 . 基于生存量表和中医证候的小儿难治性肾病临床疗效评价方法研究 [D]. 郑州 : 河南中医药大学 , 2018 .
李建平 , 蒋文明 , 韩彬 . 肾特灵组方配合西药治疗原发性肾病综合征48例临床观察 [J]. 湖南中医药导报 , 2004 , 10 ( 5 ): 20 - 21 .
孟昱林 , 王新伟 , 夏滨祥 . 健脾活血利水法治疗小儿原发性肾病综合征45例临床观察 [J]. 新中医 , 2010 , 42 ( 4 ): 29 - 30 .
马融 . 中医儿科学 [M]. 10版 . 北京 : 中国中医药出版社 , 2018 .
戴霞 , 王成岗 , 韩晓春 , 等 . 中医证候量表条目筛选的方法学探讨 [J]. 中华中医药杂志 , 2010 , 25 ( 8 ): 1168 - 1171 .
SHAH S S , HAFEEZ F . Comparison of efficacy of tacrolimus versus cyclosporine in childhood steroid-resistant nephrotic syndrome [J]. J Coll Physicians Surg Pak , 2016 , 26 ( 7 ): 589 - 593 .
GUO H L , XU J , SUN J Y , et al . Tacrolimus treatment in childhood refractory nephrotic syndrome:a retrospective study on efficacy,therapeutic drug monitoring,and contributing factors to variable blood tacrolimus levels [J]. Int Immunopharmacol , 2020 , 81 : 106290 .
王映俊 , 许静 , 景霞 , 等 . 难治性肾病综合征患儿他克莫司血药浓度监测回顾性分析 [J]. 中国医院药学杂志 , 2019 , 39 ( 6 ): 612 - 615 .
刘晓丽 , 何学红 . 中药在激素治疗肾病综合征过程中的临床应用 [J]. 辽宁中医药大学学报 , 2008 , 10 ( 12 ): 52 .
AHMED S , BERZON R A , REVICKI D A , et al . The use of patient-reported outcomes (PRO) within comparative effectiveness research:implications for clinical practice and health care policy [J]. Med Care , 2012 , 50 ( 12 ): 1060 - 1070 .
梁茂新 , 王雪峰 . 中医疗效评价指标和方法研究需要解决的认识问题 [J]. 世界科学技术—中医药现代化 , 2006 , 8 ( 1 ): 31 - 35 .
杨兆硕 , 季伟苹 , 陈沛沛 , 等 . 中医复发性口腔溃疡患者报告结局量表的研制及条目筛选 [J]. 中医杂志 , 2019 , 60 ( 8 ): 648 - 652 .
0
浏览量
23
下载量
6
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621